Lista de obras - Adam Bisaga - Dominio Público Uruguay

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

artículo científico publicado en 2018

A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers

artículo científico publicado en 2011

A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine

artículo científico publicado en 2008

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence

artículo científico publicado en 2011

A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence

artículo científico publicado en 2014

A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period

artículo científico publicado en 2010

A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders

artículo científico publicado en 2013

A randomized placebo-controlled trial of gabapentin for cocaine dependence

artículo científico publicado en 2005

A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients

artículo científico publicado en 2013

A review of a national training initiative to increase provider use of MAT to address the opioid epidemic

artículo científico publicado en 2016

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder

artículo científico publicado en 2019

Acute effects of memantine in combination with alcohol in moderate drinkers.

artículo científico publicado en 2003

Acute interaction of baclofen in combination with alcohol in heavy social drinkers

artículo científico publicado en 2008

Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder

artículo científico publicado en 2008

Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.

artículo científico publicado en 2018

Antisocial behavioral syndromes in cocaine and cannabis dependence

artículo científico publicado en 2008

Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement

artículo científico publicado en 2012

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial

artículo científico publicado en 2009

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

artículo científico publicado en 2015

Benzodiazepines and Other Sedatives and Hypnotics

artículo científico publicado en 2014

Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence

artículo científico publicado en 2009

Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice

artículo científico publicado en 2008

Clinical Studies Using NMDA Receptor Antagonists in Cocaine and Opioid Dependence

Cognition, commitment language, and behavioral change among cocaine-dependent patients

artículo científico publicado en 2008

Cognitive deficits predict low treatment retention in cocaine dependent patients.

artículo científico publicado en 2005

Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants

artículo científico publicado en 2011

Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumption.

artículo científico publicado en 2005

Comparison of substance use milestones in cannabis- and cocaine-dependent patients

artículo científico publicado en 2012

Concurrent Cannabis Use During Treatment for Comorbid ADHD and Cocaine Dependence: Effects on Outcome

Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine.

artículo científico publicado en 2013

Contemporary methods in pharmacotherapy in the opiate dependent treatment

artículo científico publicado en 2000

Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review

article

Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68]

scientific article published on 09 July 2018

Developing an opioid use disorder treatment cascade: A review of quality measures

artículo científico publicado en 2018

Development of a Cascade of Care for responding to the opioid epidemic

scientific article published on 24 January 2019

Dextromethorphan and quinidine combination for heroin detoxification

artículo científico publicado en 2008

Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?

artículo científico publicado en 2014

Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD)

artículo científico publicado en 2020

Early Abstinence in Cocaine Dependence: Influence of Comorbid Major Depression

artículo científico publicado en 2007

Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats

article

Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory.

artículo científico publicado en 2007

Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers

artículo científico publicado en 2016

Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence

artículo científico publicado en 2007

Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice

artículo científico publicado en 2003

Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers

artículo científico publicado en 2009

Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users

artículo científico publicado en 2019

Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial

artículo científico publicado en 2012

From AIDS to Opioids - How to Combat an Epidemic

artículo científico publicado en 2016

Glutamatergic Agents for Nicotine Dependence

artículo científico publicado en 2006

In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.

artículo científico publicado en 2000

Individual behavioral differences and ethanol consumption in Wistar rats.

artículo científico publicado en 1993

Innovations in pre-doctoral dental education: Influencing attitudes and opinions about patients with substance use disorder

scientific article published on 05 February 2020

Insula damage and quitting smoking.

artículo científico publicado en 2007

Interaction between naltrexone and oral THC in heavy marijuana smokers.

artículo científico publicado en 2002

Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence

artículo científico publicado en 2009

Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.

artículo científico publicado en 2015

Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine

artículo científico publicado en 2017

Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment

artículo científico publicado en 2010

Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders

artículo científico publicado en 2017

Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial

artículo científico publicado en 2021

Management of relapse in naltrexone maintenance for heroin dependence

artículo científico publicado en 2007

Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum

artículo científico publicado en 2020

Memantine reduces consumption of highly palatable food in a rat model of binge eating

artículo científico publicado en 2010

Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?

artículo científico publicado en 2013

Open-label pilot study of quetiapine treatment for cannabis dependence

artículo científico publicado en 2014

Opiate withdrawal with dextromethorphan

scientific article published on 01 April 1997

Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice

artículo científico publicado en 2012

Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism

scientific article published on 04 August 2019

Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone

artículo científico publicado en 2014

Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the blockade as a predictor of retention in treatment

artículo científico publicado en 2017

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.

artículo científico publicado en 2018

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

artículo científico publicado en 2017

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

scientific article published on 29 June 2020

Quetiapine treatment for cannabis use disorder

artículo científico publicado en 2020

Recognition cue in the rat's social memory paradigm

artículo científico publicado en 1991

Reinstatement of morphine-conditioned reward is blocked by memantine

artículo científico publicado en 2006

Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246

artículo científico publicado en 2020

Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers

artículo científico publicado en 2006

Sex differences and hormonal influences on response to cold pressor pain in humans.

artículo científico publicado en 2006

Sex differences and hormonal influences on response to mechanical pressure pain in humans

artículo científico publicado en 2009

Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients

artículo científico publicado en 2005

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

artículo científico publicado en 2001

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

artículo científico publicado en 2018

The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity

artículo científico publicado en 2020

The acute effects of gabapentin in combination with alcohol in heavy drinkers.

artículo científico publicado en 2005

The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone

artículo científico publicado en 2015

The effects of nicotine administration and drug cue on impulsivity

artículo científico publicado en 2017

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

artículo científico publicado en 2000

Utility of lead-in period in cocaine dependence pharmacotherapy trials

artículo científico publicado en 2005

What should clinicians do as fentanyl replaces heroin?

artículo científico publicado en 2019

Lista de obras de Adam Bisaga

A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder

A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers

A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine

A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence

A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence

A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period

A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders

A randomized placebo-controlled trial of gabapentin for cocaine dependence

A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients

A review of a national training initiative to increase provider use of MAT to address the opioid epidemic

A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder

Acute effects of memantine in combination with alcohol in moderate drinkers.

Acute interaction of baclofen in combination with alcohol in heavy social drinkers

Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder

Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.

Antisocial behavioral syndromes in cocaine and cannabis dependence

Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

Benzodiazepines and Other Sedatives and Hypnotics

Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence

Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice

Clinical Studies Using NMDA Receptor Antagonists in Cocaine and Opioid Dependence

Cognition, commitment language, and behavioral change among cocaine-dependent patients

Cognitive deficits predict low treatment retention in cocaine dependent patients.

Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants

Comparison of serum fatty acid ethyl esters and urinary 5-hydroxytryptophol as biochemical markers of recent ethanol consumption.

Comparison of substance use milestones in cannabis- and cocaine-dependent patients

Concurrent Cannabis Use During Treatment for Comorbid ADHD and Cocaine Dependence: Effects on Outcome

Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine.

Contemporary methods in pharmacotherapy in the opiate dependent treatment

Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review

Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68]

Developing an opioid use disorder treatment cascade: A review of quality measures

Development of a Cascade of Care for responding to the opioid epidemic

Dextromethorphan and quinidine combination for heroin detoxification

Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?

Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial

Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD)

Early Abstinence in Cocaine Dependence: Influence of Comorbid Major Depression

Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats

Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory.

Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers

Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence

Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice

Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers

Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users

Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial

From AIDS to Opioids - How to Combat an Epidemic

Glutamatergic Agents for Nicotine Dependence

In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists.

Individual behavioral differences and ethanol consumption in Wistar rats.

Innovations in pre-doctoral dental education: Influencing attitudes and opinions about patients with substance use disorder

Insula damage and quitting smoking.

Interaction between naltrexone and oral THC in heavy marijuana smokers.

Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence

Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'.

Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine

Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment

Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders

Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial

Management of relapse in naltrexone maintenance for heroin dependence

Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum

Memantine reduces consumption of highly palatable food in a rat model of binge eating

Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?

Open-label pilot study of quetiapine treatment for cannabis dependence

Opiate withdrawal with dextromethorphan

Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice

Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism

Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone

Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the blockade as a predictor of retention in treatment

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

Quetiapine treatment for cannabis use disorder

Recognition cue in the rat's social memory paradigm

Reinstatement of morphine-conditioned reward is blocked by memantine

Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246

Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers